ZURICH, May 21, 2015 /PRNewswire/ --
Welcome news for the Haselmeier Group - two of their products scooped top prizes at the GOOD DESIGN™ Awards. This re-affirms the successful corporate philosophy of Haselmeier: The implementation of innovative ideas into high-quality products to further strengthen and expand the position of Haselmeier on the international stage.
The "Chicago Athenaeum Museum of Architecture and Design" and the "European Centre for Architecture Art Design and Urban Studies" honored both of our products
Merck Serono Fertility Pen 1.0 / 1.1
with the GOOD DESIGN™ Award.
The Axis-D is a disposable delivery system from the Haselmeier Pen platform and designed for use with a 3 ml cartridge. Administering variable doses of medication ranging from 0.01 to 0.8 ml, the cutting-edge technology allows customizable incremental doses. Accurate dose reading with sliding window. Dose correction helps to avoid injection errors or even a loss of product.
The Merck Serono Fertility Pen 1.0/1.1 was also exclusively developed for our customers based on the Axis-D platform and designed to simplify fertility treatment in patients. Various filling and maximum dose volumes can be used so that it is possible to use the same pen within the entire fertilization product family. The Merck Serono Fertility pen is in worldwide use today.
Information on the Award
Founded in Chicago in 1950, GOOD DESIGN is the world's oldest and most prestigious institution for design excellence. The jury met in New York and Los Angeles in October 2014 and selected from more than 700 products for design and graphics from over 36 nations, those worthy of an award. All prizes and winners are published on the museum's homepage at: http://www.chi-athenaeum.org . Moreover, all award-winning products and graphics appear in the "GOOD DESIGN Yearbook 2014-2015".
Founded in Stuttgart in 1920, Haselmeier is a global medical device company and a leading designer and manufacturer of pen and auto injection systems. The devices feature unique function, design and technology and are marketed by leading pharmaceutical and biotechnology companies around the world. Located in five locations across three continents, we develop and produce innovative technologies for administering medication to improve the health and everyday life of patients.
For more information please visit http://www.haselmeier.com
Nadia Di Secli
SOURCE Haselmeier AG